Tussin Syrup: Each 5 ml syrup contains Guaiphenesin BP 100 mg, Pseudoephedrine hydrochloride BP 30 mg and Triprolidine hydrochloride BP 1.25 mg.
Tussin is indicated for symptomatic relief of cough, respiratory tract disorder, as decongestant for cough associated with cold & allergic manifestations etc.
Tussin is contraindicated in patients with a known hypersensitivity to Guaiphenesin, Pseudoephdrine or Triprolidine. It should not be administered within 14 days following administration of MAO inhibitors; it is also contraindicated in patients with severe hypertension or severe coronary artery disease.
Dosage & Administration
Adult & over 12 years: 2 teaspoonful three times a day
6-12 years : 1 teaspoonful three times a day
2-5 years : 1/2 teaspoonful three times a day
Occasionally may cause CNS depression, excitation, hallucination, dizziness, weakness, palpitation, tachycardia, nausea, vomiting etc.
Tussin should be used with caution in the patients of cardiovascular disease, diabetes mellitus, abnormal thyroid function, prostatic hypertrophy, hypertension, functional impairment of liver and kidney. Tussin may cause drowsiness & impair performance in tests of auditory vigilance. Patients
It is not known whether the components of Tussin syrup can cause fetal harm when administered to pregnant women or whether they affect reproductivity.
should not drive or operate machinery until they have determined their own response.
Patients taking beta blockers, MAO inhibitors or antihypertensive agents should take Tussin on the advice & under supervision of physician. Concurrent use with beta blockers & MAO inhibitors may increase the pressor effect of Pseudoephedrine and with antihypertensive; hypotensive effects of antihypertensive may be decreased.